Perioperative medicine
Conditions
Interventions
Remimazolam combined with Ropivacaine group:Ropivacaine combined with remimazolam is an injectable drug for intramuscular groove brachial plexus block under ultrasound guidance
Ropivacaine group:Ropivacaine is an injectable drug for ultrasound-guided brachial plexus block in the intermuscular groove
Sponsors
The 980th Hospital of Joint Logistic Support Force
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: ASA Grade I-II patients with ulnar and radius fractures aged 18-80 years with body mass index (BMI)20-30 kg/m^2 and normal cognitive function.
Exclusion criteria
Exclusion criteria: Patients with a history of allergy to any trial medication, presence of coagulation dysfunction, infection at the nerve block puncture site, ingestion of any pain medication within 48 hours before surgery, history of chronic pain medication use, history of trauma or thoracic surgery, sinus bradycardia, atrioventricular block, and other conditions not eligible for this study and those who participated in other trials within one month. The patient or family member refused.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue pain score 8h after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS score 30min after block;First rescue analgesia time;Patient satisfaction with pain management;Evaluation of sensory block in affected limb;Sensorimotor assessment of affected limb;Hemodynamics during surgical incision; | — |
Countries
China
Contacts
Public ContactWu Yu
The 980th Hospital of Joint Logistic Support Force
Outcome results
None listed